GPCR Earnings Structure Therapeutics Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–17 of 17
| Q1 2026 | 2026-03-31 | -0.35 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.80 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | -1.00 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.63 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.27 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -0.78 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | -0.56 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.36 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.19 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | -0.81 | 2026-02-26 | 10-K |
| Q3 2024 | 2023-09-30 | -0.65 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.44 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.25 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -5.51 | 2024-03-08 | 10-K |
| Q3 2023 | 2022-09-30 | -4.34 | 2023-11-17 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.09 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.44 | 2023-05-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.